Design and synthesis of novel pyrimidine analogs as highly selective, non-covalent BTK inhibitors

被引：14

作者：

Kawahata, Wataru ^{[1
]}

Asami, Tokiko ^{[1
]}

Irie, Takayuki ^{[1
]}

Sawa, Masaaki ^{[1
]}

机构：

[1] Carna Biosci Inc, Res & Dev, BMA, Chuo Ku, 3rd Floor,1-5-5 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2018年 / 28卷 / 02期

关键词：

Bruton's tyrosine kinase; Kinase inhibitor; Kinase selectivity; Pyrimidine; Passive cutaneous anaphylaxis; BRUTONS TYROSINE KINASE; TEC FAMILY KINASES; B-CELL; ARTHRITIS; POTENT;

D O I：

10.1016/j.bmcl.2017.11.037

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

BTK is a promising target for the treatment of multiple diseases such as B cell malignances, asthma, and rheumatoid arthritis. Here, we report the discovery of a series of novel pyrimidine analogs as potent, highly selective, non-covalent inhibitors of BTK. Compound 25d demonstrated higher affinity to an unactivated conformation of BTK that resulted in an excellent kinase selectivity. Compound 25d showed a good oral bioavailability in mice, and significantly inhibits the PCA reaction in mice. (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：145 / 151

页数：7

共 50 条

[21] Exploiting non-covalent interactions in selective carbohydrate synthesis
Loh, Charles C. J.
[J]. NATURE REVIEWS CHEMISTRY, 2021, 5 (11) : 792 - 815
[22] CFON-026 is a potent non-covalent BTK inhibitor suitable for combination therapy with covalent BTK inhibitors for early eradication of resistance mutations
de Man, Jos
Muller, Michelle
Uitdehaag, Joost C. M.
van Cauter, Freek
van Gemert, Sander
Hoffmann, Milan
van Mil, Yvonne G. T. H.
Mulder, Winfried R.
Prinsen, Martine B. W.
Sterrenburg, Jan Gerard
Vu, Diep
de Wit, Joeri
Ensing, Erik
Buijsman, Rogier C.
[J]. CANCER RESEARCH, 2024, 84 (06)
[23] Non-Covalent BTK Inhibitors-The New BTKids on the Block for B-Cell Malignancies
Lewis, Katharine L.
Cheah, Chan Y.
[J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
[24] Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors
Ma, Bin
Metrick, Claire M.
Gu, Chungang
Hoemberger, Marc
Bajrami, Bekim
Bame, Eris
Huang, Jiansheng
Mingueneau, Michael
Murugan, Paramasivam
Santoro, Joseph C.
Tang, Hao
Wang, Ti
Hopkins, Brian T.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 60
[25] Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit
Qiu, Hui
Liu-Bujalski, Lesley
Caldwell, Richard D.
Follis, Ariele Viacava
Gardberg, Anna
Goutopoulos, Andreas
Grenningloh, Roland
Head, Jared
Johnson, Theresa
Jones, Reinaldo
Mochalkin, Igor
Morandi, Federica
Neagh, Constantin
Sherer, Brian
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (17) : 2939 - 2944
[26] Arylaminoethyl amides as novel non-covalent cathepsin K inhibitors
Altmann, E
Renaud, J
Green, J
Farley, D
Cutting, B
Jahnke, W
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) : 2352 - 2354
[27] The design of highly potent non-covalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site.
Tucker, TJ
Lumma, WC
Mulichak, AM
Chen, ZG
Kuo, LM
NaylorOlsen, AM
Lewis, SD
Lucas, R
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 198 - MEDI
[28] Identification of Potent and Selective Non-covalent Inhibitors of the Plasmodium falciparum Proteasome
Li, Hao
Tsu, Christopher
Blackburn, Christopher
Li, Gang
Hales, Paul
Dick, Lawrence
Bogyo, Matthew
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (39) : 13562 - 13565
[29] Design and synthesis of a macrocyclic non-covalent proteasome inhibitor
Rocha, Megan
Dorn, Robert
Gotz, Marion
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[30] Design and synthesis of a non-covalent macrocyclic proteasome inhibitor
Palmer, Mathias
Dorn, Robby
Rocha, Megan
Merrill-Steskal, Gabriel
Gotz, Marion
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253

← 1 2 3 4 5 →